Primary |
Drug Use For Unknown Indication |
31.8% |
Schizophrenia |
18.2% |
Depression |
13.6% |
Affective Disorder |
9.1% |
Mental Disorder |
9.1% |
Anxiety Disorder |
4.5% |
Insomnia |
4.5% |
Psychotic Disorder |
4.5% |
Schizoid Personality |
4.5% |
|
Tremor |
12.5% |
Facial Palsy |
6.3% |
Insomnia |
6.3% |
Memory Impairment |
6.3% |
Muscle Tightness |
6.3% |
Nerve Injury |
6.3% |
No Adverse Reaction |
6.3% |
Paralysis |
6.3% |
Prothrombin Time Prolonged |
6.3% |
Suicide Attempt |
6.3% |
Tachycardia |
6.3% |
Tardive Dyskinesia |
6.3% |
Urine Output Decreased |
6.3% |
Vomiting |
6.3% |
Weight Decreased |
6.3% |
|
Secondary |
Bipolar Disorder |
21.4% |
Bipolar I Disorder |
11.4% |
Depression |
11.4% |
Schizophrenia |
11.4% |
Psychotic Disorder |
7.1% |
Anxiety |
5.7% |
Anger |
4.3% |
Smoking Cessation Therapy |
4.3% |
Drug Use For Unknown Indication |
2.9% |
Hypercholesterolaemia |
2.9% |
Ill-defined Disorder |
2.9% |
Mania |
2.9% |
Affective Disorder |
1.4% |
Antisocial Behaviour |
1.4% |
Bacterial Infection |
1.4% |
Blood Cholesterol Increased |
1.4% |
Diabetes Mellitus |
1.4% |
Emphysema |
1.4% |
Gastrooesophageal Reflux Disease |
1.4% |
Hallucination |
1.4% |
|
Weight Increased |
14.8% |
Sedation |
7.4% |
Tardive Dyskinesia |
7.4% |
Tendonitis |
7.4% |
Upper Respiratory Tract Infection |
7.4% |
Cerebrovascular Accident |
3.7% |
Drug Hypersensitivity |
3.7% |
Insomnia |
3.7% |
Medication Error |
3.7% |
Muscle Spasms |
3.7% |
Parkinson's Disease |
3.7% |
Photosensitivity Reaction |
3.7% |
Psychotic Disorder |
3.7% |
Salivary Hypersecretion |
3.7% |
Somnolence |
3.7% |
Systemic Lupus Erythematosus |
3.7% |
Treatment Noncompliance |
3.7% |
Tremor |
3.7% |
Type 2 Diabetes Mellitus |
3.7% |
Visual Disturbance |
3.7% |
|
Concomitant |
Depression |
18.8% |
Schizophrenia |
17.4% |
Bipolar Disorder |
13.9% |
Anxiety |
8.7% |
Sleep Disorder |
5.6% |
Insomnia |
4.5% |
Bipolar I Disorder |
3.3% |
Pain |
3.3% |
Schizoaffective Disorder |
3.1% |
Hypertension |
2.9% |
Agitation |
2.6% |
Psychotic Disorder |
2.5% |
Diabetes Mellitus |
2.0% |
Drug Use For Unknown Indication |
2.0% |
Product Used For Unknown Indication |
1.8% |
Gastrooesophageal Reflux Disease |
1.8% |
Schizophrenia, Paranoid Type |
1.8% |
Paranoia |
1.7% |
Mental Disorder |
1.2% |
Cardiac Disorder |
1.2% |
|
Type 2 Diabetes Mellitus |
33.4% |
Weight Increased |
12.4% |
Tardive Dyskinesia |
9.7% |
Diabetes Mellitus |
5.3% |
Pancreatitis |
4.7% |
Type 1 Diabetes Mellitus |
3.7% |
Suicide Attempt |
3.2% |
Pain In Extremity |
2.9% |
White Blood Cell Count Decreased |
2.9% |
Diabetic Ketoacidosis |
2.4% |
Suicidal Ideation |
2.4% |
Withdrawal Syndrome |
2.4% |
Diabetic Coma |
2.1% |
Mental Disorder |
2.1% |
Throat Tightness |
2.1% |
Somnolence |
1.8% |
Urinary Tract Infection |
1.8% |
Hypertension |
1.6% |
Sleep Apnoea Syndrome |
1.6% |
Sleep Disorder |
1.6% |
|
Interacting |
Parkinson's Disease |
62.5% |
Schizophrenia |
37.5% |
|
Drug Interaction |
50.0% |
Sedation |
50.0% |
|